Gene · 6421
NIH grants1,450
NIH grants whose papers are about the gene, through NIH's grant-paper links.
441 to 460 of 1,450
Download this page as JSON| Grant | Title | SFPQ papers | Newest fiscal year |
|---|---|---|---|
| F31AI164671 | Suppression of Host Antiviral Responses by a SARS-CoV-2 Histone Mimetic | 1 | 2022 |
| F31CA250136 | Unraveling the influence of genetic subtype on spatial configurations of tissue and immune compartment composition in clear cell renal cell carcinoma | 1 | 2022 |
| F31CA257637 | IncRNA BORG Mediates Alternative Splicing to Enhance Cellular Plasticity in TNBC | 1 | 2022 |
| I01BX003689 | Mechanisms for treating ischemic wounds with human adipocyte derived stem cell exosomes | 1 | 2022 |
| K01AG062796 | Tau Kinetics in the human CNS in vivo and in vitro | 1 | 2022 |
| K99CA255936 | Mechanisms of translational output control in pancreatic cancer | 1 | 2022 |
| K99CA273170 | A new multi-pathway kinase activity assay applied to compound library screening in cancer biology | 1 | 2022 |
| P01AI062885 | Epithelial innate signaling in airway inflammation and remodeling | 1 | 2022 |
| P30DK079307 | Pittsburgh Center for Kidney Research | 1 | 2022 |
| P41EB015902 | Neuroimaging Analysis Center (NAC) | 1 | 2022 |
| R00HD094906 | Exploring novel regulatory mechanisms underlying enhancer activation and cell fate transition | 1 | 2022 |
| R01AI103338 | Enhancing Pathogen-specific Memory CD8+ T cell Responses in Vivo | 1 | 2022 |
| R01AI132526 | The role of UBXNs in antiviral immunity | 1 | 2022 |
| R01AR070245 | Metabolic Control of Hair Follicle Stem Cell Homeostasis and Tumorigenesis | 1 | 2022 |
| R01CA215063 | Targeting KDM4B, a novel alternative splicing regulator, in castration-resistant prostate cancer (CRPC) | 1 | 2022 |
| R01CA219850 | (PQ5) Contribution of mitochondrial pathways to metabolic heterogeneity in molecular subtypes of Diffuse Large B Cell Lymphoma | 1 | 2022 |
| R01CA221296 | The Role of Stromal Autophagy in Cutaneous Melanoma | 1 | 2022 |
| R01CA224342 | Epigenetic Mechanisms of Drug Resistance in Renal Cell Carcinoma | 1 | 2022 |
| R01CA227001 | A SIGNALING PATHWAY SPECIFIC FOR ALKYLATION DAMAGE | 1 | 2022 |
| R01DA046171 | Identification and Regulation of RNA Modification by HIV infection and Methamphetamine | 1 | 2022 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6421/grants?page=23